GetTopicDetailResponse(id=3604645e84c, topicName=治療中斷, introduction=治療中斷, content=null, image=null, comments=4, allHits=1143, url=https://h5.medsci.cn/topic?id=64578, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=67946, tagList=[TagDto(tagId=67946, tagName=治療中斷)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2079173, encodeId=f49320e91738b, content=<a href='/topic/show?id=3604645e84c' target=_blank style='color:#2F92EE;'>#治療中斷#</a>, objectTitle=J Clin Oncol：卡培他濱維持 vs 治療中斷對(duì)一線治療后病情穩(wěn)定的轉(zhuǎn)移性結(jié)直腸癌患者預(yù)后和生活質(zhì)量的影響, objectType=article, longId=217140, objectId=67cd21e14003, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67cd21e14003, replyNumber=0, likeNumber=100, createdTime=2022-06-12, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67cd21e14003, moduleTitle=J Clin Oncol：卡培他濱維持 vs 治療中斷對(duì)一線治療后病情穩(wěn)定的轉(zhuǎn)移性結(jié)直腸癌患者預(yù)后和生活質(zhì)量的影響, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=67cd21e14003)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079172, encodeId=a67c20e917269, content=<a href='/topic/show?id=3604645e84c' target=_blank style='color:#2F92EE;'>#治療中斷#</a>, objectTitle=Clin Gastroenterology H： 乙型肝炎核心蛋白抗體血清水平與核苷酸（t）類似物治療中斷后的臨床復(fù)發(fā)相關(guān), objectType=article, longId=157891, objectId=f99915e89149, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f99915e89149, replyNumber=0, likeNumber=94, createdTime=2019-04-06, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f99915e89149, moduleTitle=Clin Gastroenterology H： 乙型肝炎核心蛋白抗體血清水平與核苷酸（t）類似物治療中斷后的臨床復(fù)發(fā)相關(guān), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f99915e89149)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079171, encodeId=cd4420e917136, content=<a href='/topic/show?id=3604645e84c' target=_blank style='color:#2F92EE;'>#治療中斷#</a>, objectTitle=Pharmacotherapy：新型直接口服抗凝劑減少治療中斷 噱頭還是事實(shí)？, objectType=article, longId=129090, objectId=70a91290900a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70a91290900a, replyNumber=0, likeNumber=105, createdTime=2018-03-09, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70a91290900a, moduleTitle=Pharmacotherapy：新型直接口服抗凝劑減少治療中斷 噱頭還是事實(shí)？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=70a91290900a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079170, encodeId=1b2d20e917017, content=<a href='/topic/show?id=3604645e84c' target=_blank style='color:#2F92EE;'>#治療中斷#</a>, objectTitle=JAMA Inter Med：華法林治療中斷后復(fù)發(fā)性靜脈血栓栓塞、出血和死亡風(fēng)險(xiǎn), objectType=article, longId=51333, objectId=10d35133372, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10d35133372, replyNumber=0, likeNumber=103, createdTime=2015-07-23, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10d35133372, moduleTitle=JAMA Inter Med：華法林治療中斷后復(fù)發(fā)性靜脈血栓栓塞、出血和死亡風(fēng)險(xiǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=10d35133372)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
